FOLFIRINOX + NIS793 in Pancreatic Cancer
Phase 1 Terminated
4 enrolled
Lithium
Phase 1 Terminated
2 enrolled
Trial of Tolcapone With Oxaliplatin for Neuroblastoma
Phase 1 Terminated
5 enrolled
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Phase 1 Terminated
2 enrolled
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Phase 1 Terminated
27 enrolled
SENTINEL
Phase 1 Terminated
10 enrolled 13 charts
IPOX-FOLFIRI
Phase 1 Terminated
1 enrolled
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 1 Terminated
36 enrolled 17 charts
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors
Phase 1 Terminated
41 enrolled
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
Phase 1 Terminated
24 enrolled
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
Phase 1 Terminated
4 enrolled
Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
Phase 1 Terminated
3 enrolled
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Phase 1 Terminated
16 enrolled
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Phase 1 Terminated
40 enrolled
Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
Phase 1 Terminated
30 enrolled
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
Phase 1 Terminated
12 enrolled
Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 1 Terminated
9 enrolled
GlivecĀ® Plus m-FOLFOX AvastinĀ® in Advanced Colorectal Cancer
Phase 1 Terminated
10 enrolled